Literature DB >> 6758692

Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives.

M R Jacobs, F Kelly, W T Speck.   

Abstract

The susceptibility of 100 group B streptococci to 16 beta-lactam antibiotics was tested by agar dilution. Penicillin G and N-formimidoyl thienamycin were the most active agents tested, both having a 90% minimal inhibitory concentration (MIC90) of 0.06 microgram/ml. Ceftriaxone, cefotaxime, cefamandole, and SCH 29482 were almost as active, all having an MIC90 of 0.12 microgram/ml, and ampicillin, cephalothin, and mezlocillin all had an MIC90 of 0.25 microgram/ml. The MIC90 for piperacillin, cefoperazone, and ceftazidime was 0.5 microgram/ml. Least active were carbenicillin, ticarcillin, cefoxitin, and moxalactam, with MIC90s of 1, 2, 4, and 8 micrograms/ml, respectively. No penicillin-tolerant strains were detected.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6758692      PMCID: PMC185679          DOI: 10.1128/AAC.22.5.897

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis.

Authors:  W E Feldman
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

2.  Pharmacologic studies in neonates given large dosages of ampicillin.

Authors:  J M Kaplan; G H McCracken; L J Horton; M L Thomas; N Davis
Journal:  J Pediatr       Date:  1974-04       Impact factor: 4.406

3.  New method for the serological grouping of Streptococci with specific antibodies adsorbed to protein A-containing staphylococci.

Authors:  P Christensen; G Kahlmeter; S Jonsson; G Kronvall
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

4.  Neonatal septicemia and meningitis.

Authors:  G H McCracken
Journal:  Hosp Pract       Date:  1976-01

5.  Presumptive identification and antibiotic susceptibility of group B streptococci.

Authors:  A M Jokipii; L Jokipii
Journal:  J Clin Pathol       Date:  1976-08       Impact factor: 3.411

6.  Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci.

Authors:  C N Baker; C Thornsberry; R R Facklam
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

7.  Importance of medium in demonstrating penicillin tolerance by group B streptococci.

Authors:  K S Kim; R N Yoshimori; D T Imagawa; B F Anthony
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

8.  Antagonism of ampicillin and chloramphenicol for meningeal isolates of group B streptococci.

Authors:  J L Weeks; E O Mason; C J Baker
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

9.  Hypersusceptibility of penicillin-treated group B streptococci to bactericidal activity of human polymorphonuclear leukocytes.

Authors:  D Horne; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

Review 10.  Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.

Authors:  S H Landesman; M L Corrado; P M Shah; M Armengaud; M Barza; C E Cherubin
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

View more
  11 in total

1.  Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.

Authors:  M Fernandez; M E Hickman; C J Baker
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

2.  Reverse inoculum effect in bactericidal activity and other variables affecting killing of group B streptococci by penicillin.

Authors:  L Jokipii; P Brander; A M Jokipii
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

3.  Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci.

Authors:  C Betriu; M Gomez; A Sanchez; A Cruceyra; J Romero; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

4.  Common bacterial pathogens and resistance to antibiotics.

Authors:  P J Sanderson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-15

5.  The potential uses of ceftriaxone.

Authors:  W M Scheld
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

6.  Neonatal group B streptococcal meningitis.

Authors:  C J Mulder; H C Zanen
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

Review 7.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

Review 8.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

Review 9.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

Review 10.  Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; D M Richards; R N Brogden; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.